Seoul
South Korea
7
2025-05-08
3
2023-07-18
These are the the leading inventors for applications assigned to GENUV INC.:
GENUV INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CYTOKINE FUSION PROTEIN
#2 | 2025-02-27STABLE LIQUID PHARMACEUTICAL FORMULATION
#3 | 2024-02-01ANTI-PD-1 ANTIBODY AND USE THEREOF
#4 | 2023-06-22Method and Composition for Evaluating Response to Neurodegenerative Disease Treatment Agent
#5 | 2021-12-30 ✅ Patent 11,701,360 granted on 2023-07-18Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition
#6 | 2020-02-13 ✅ Patent 11,147,816 granted on 2021-10-19Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition
#7 | 2018-06-21 ✅ Patent 10,485,802 granted on 2019-11-26Composition for inducing differentiation and protection of neural stem cells and method for inducing neuro-regeneration using the same composition
Also check out GENUV Inc.'s (Seoul, South Korea) applicant profile with 5 patent applications submitted.
338427 ⎘